WCPO: Experts: Recent surge could trigger COVID-related PTSD
UC expert says keeping connected is important
A surge in cases of COVID-19 can cause more than just physical problems. For some survivors of COVID, the mental toll can include bouts of post traumatic stress disorder, or PTSD. In a story produced by WCPO, Maria Espinola, PsyD, assistant professor in the Department of Psychiatry and Behavioral Neuroscience at the UC College of Medicine stressed the importance of maintaining a connection to family and friends.
"One of the symptoms for PTSD is avoidance,” said Espinola. She recommends those who are suffering from PTSD take care of themselves. She said exercising, eating well, getting therapy and connecting with others could help.
“At the very least, make a phone call,” Espinola said. “Have a Zoom meeting, connect through social media, but don't isolate.”
Lead photo of Maria Espinola/Colleen Kelley/UC Creative + Brand
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.